ALG1L10P

Across TCGA pan-cancer cohorts, ALG1L10P RNA is linked to patient survival in 25 of 34 cancer types, making it the most broadly survival-associated ALG1L10P data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher ALG1L10P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated ALG1L10P expression acts as an unfavorable survival marker, although some lineages such as LGG and UCS show a favorable association.

ACC, KIRC, and LUAD are the cancer types where ALG1L10P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	OS	Median	All	0.405	0.824	<.001	76	view →
KIRC	DFS	Quartile	IV	0.195	0.472	.005	26	view →
LUAD	DFS	Median	IV	0.272	0.804	.006	24	view →
DLBC	DFS	Median	III,IV	0.525	1.000	.013	20	view →
LGG	OS	Tertile	All	0.934	0.834	<.001	19	view →
THCA	DFS	Quartile	IV	0.587	0.940	.012	19	view →
UCS	DFS	Tertile	III,IV	0.447	0.096	.007	18	view →
CHOL	DFS	Median	II,III,IV	0.121	0.626	.002	15	view →
SKCM	DFS	Quartile	All	0.702	0.542	.004	14	view →
LIHC	OS	Median	All	0.711	0.844	.002	14	view →
CESC	OS	Tertile	IV	0.861	0.204	.029	12	view →
GBM	OS	Quartile	All	0.206	0.361	.015	11	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 25 lineages.

ALG1L10P–ACC (OS)

Open the ACC breakdown →